Gemcitabine and Docetaxel Combination Chemotherapy for Advanced Bone and Soft Tissue Sarcomas: Protocol for an Open-Label, Non-Randomised, Phase 2 Study
BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5923-7
Full Text
Open PDFAbstract
Available in full text
Date
July 23, 2019
Authors
Publisher
Springer Science and Business Media LLC